Å.V. Kochurova1, S.V. Kozlov1, V.N. Nikolenko1,2
1I.M. Sechenov First Moscow State
Medical University, 119991, Moscow,
Russian Federation; 2 M.V.
Lomonosov Moscow State University, 119192, Moscow, Russian Federation
The role of biomarkers
oral fluid in the definition of the dental status of cancer patients
The acuteness of the situation with
oncological diseases of the best of all the statistics. Today, cancer is one of
the three (along with diseases of the cardiovascular system, as well as
injuries and poisonings) reasons super mortality in Russia: every year from it
kills nearly 300 thousand people, of which more than 170 thousand. - under the
age of 70 years. Despite this, more than 450 000 new cases of cancer is
revealed in Russia, this means that diagnosed approximately one oncological disease in a minute.
Dental status is an inalienable
confirmation of the hygiene of the oral cavity, which, in turn, contributes to
the correct choice of the appropriate method of treatment. Level of
mineralization of dental solid tissues, the intensity of caries process, the
state of soft tissues of parodentium - they are all together and individually,
will show the dental status of the patient and determine the final decision on
the choice of the treatment method. The level and quality of personal hygiene
of oral cavity of the patient, often determine not only the amount of dental
care, but provide a distant forecasting based on the results of the conducted
treatment.
To assess the dental status in patients
with pathological processes in maxillofacial region, with the primary
admissions in specific Department assessment complaints of the patients, the
hard/soft plaque, caries, periodontal tissue, fillings and orthopedic prosthesis. For examination prosthetic
dental prosthesis patient paid particular attention to the presence of chipped
teeth and/or prostheses, depreciation and functionality, and during the
examination of prosthetic field - injury of the mucous membrane of the mouth
cavity (MMMC) in the area of prosthetic.
During
the examination of dental status in patients with the acquired defects of the
maxilla-facial region most often greeted the presence of over-/sub gingival
plaque and injury of the MMMC in the area of prosthetic (66,0% 66,8%,
respectively). Dental care as caries of tooth crown treatment - 47,3%, pulpitis
- 23,9%, periodontitis 18,5% of the cases. Crowns and bridges design of
orthopedic prostheses were seen in 47,7% of patients. Among them met metal
prosthesis forged-pressure welded - 7,5% and solid - 13,0%. Detachable design
met the 31,9% of cases, dominated dentures - 23,2%. Sanitation of the oral
cavity were seen in 13,9% of patients with acquired defects of the
maxillofacial region (table 1).
Determination
of the expression biomarkers (MMP-2, 8, 9, TIMP-1, 2, ÑÀ 72-4,
19-9, 125, AFP, CEÀ,
NSE, ÑYFRA
21-1, PSA, HGCh) in the oral fluid a statistically
significant difference (ð≤0,05)
and diagnostic (DS≥60%) revealed by MMP-2, MMP-8, TIMP-1, TIMP-2, CEA and
CA 125 compared with the group of control (GC) (table 2, figure 1).
Expression of biomarkers oral fluid
varies depending on the dental status: the state of hygiene of the oral cavity,
presence and type of orthopedic constructions and based on need in dental care.
So, examinations of dental status and expression biomarkers oral fluid in
cancer patients is necessary for compiling the somatic status of this group of
patients.
Table 1
Dental care of the patients with the
oncology defects of the maxillofacial region
|
Dental care |
n=656 |
% |
|
Dental plaque |
433 |
66,0% |
|
Chipped
of the tooth/prosthesis |
373 |
56,9% |
|
Caries
crown of the tooth |
310 |
47,3% |
|
Pulpitis |
157 |
23,9% |
|
Periodontitis |
121 |
18,5% |
|
Disease MMMC |
438 |
66,8% |
|
Fillings |
373 |
56,9% |
|
Crown
or/and bridges: |
313 |
47,7% |
|
-
Forged-pressure welded -
Solid-without lining - Metaloplastic - Metaloceramic |
49 85 63 115 |
7,5% 13,0% 9,6% 17,5% |
|
Non-fixed
denture: |
209 |
31,9% |
|
- Full denture - Clasp denture |
56 152 |
8,5 23,2 |
|
Oral
cavity sanation |
91 |
13,9% |
Table
2
Expression
of biomarkers salivary fluid (M±m)
|
Biomarkers |
GC n=65 |
Plague n=433 |
Caries n=310 |
Chipped n=373 |
MMMC n=438 |
Fixed denture n=313 |
Non-fixed denture n=209 |
Sanation n=91 |
|
MMP -2 |
2,29±0,4 |
6,3±1,2 |
6,1±1,3 |
6,6±1,1 |
9,1±1,51 |
5,9±1,4 |
4,3±0,8 |
4,4±0,8 |
|
MMP -8 |
31,75±10,1 |
1079,8±169,41 |
897,5±157,91 |
945,8±136,21 |
1150,6±179,11 |
910,8±168,7 |
743,6±161,11 |
819,1±159,71 |
|
MMP -9 |
403,13±69,8 |
958,9±104,7 |
904,2±103,1 |
965,6±89,0 |
1154,7±116,71 |
923,3±107,8 |
650,9±120,8 |
876,2±113,6 |
|
ÒIMP -1 |
86,03±11,7 |
313,9±30,31 |
282,1±29,6 |
296,1±25,71 |
335,2±31,51 |
276,9±29,11 |
253,9±36,41 |
248,2±29,61 |
|
ÒIMP -2 |
8,74±1,5 |
36,3±3,81 |
32,5±3,61 |
35,1±3,21 |
40,3±4,21 |
35,1±4,01 |
34,7±5,61 |
30,5±3,71 |
|
ÑÀ 72-4 |
11,2±3,85 |
19,2±2,01 |
—— |
19,2±2,11 |
17,8±1,61 |
—— |
—— |
20,0±2,21 |
|
ÑÀ 19-9 |
277,6±61,4 |
674,2±187,8 |
—— |
674,2±187,8 |
705,5±167,2 |
—— |
—— |
675,3±187,7 |
|
AFP |
5,2±0,1 |
8,0±0,31 |
—— |
8,0±0,31 |
7,9±0,31 |
—— |
—— |
8,0±0,31 |
|
CEÀ |
83±10,8 |
644,7±112,01 |
—— |
644,7±112,01 |
555,2±83,71 |
—— |
—— |
658,1±112,11 |
|
ÑÀ 125 |
573,3±68,6 |
1903,7±365,71 |
—— |
1093,7±365,71 |
1750,9±285,11 |
—— |
—— |
2146,1±414,71 |
|
NSÅ |
4,3±0,3 |
5,5±1,0 |
—— |
5,5±1,0 |
5,6±0,8 |
—— |
—— |
6,3±1,3 |
|
ÑYFRA 21-1 |
13,99±0,6 |
35,4±9,01 |
—— |
35,4±9,01 |
28,3±5,81 |
—— |
—— |
36,5±9,01 |
|
PSA |
0,3±0,02 |
1,1±0,4 |
—— |
1,1±0,4 |
0,8±0,3 |
—— |
—— |
0,8±0,3 |
|
HGCh |
1,9±0,5 |
3,5±0,8 |
—— |
3,5±0,8 |
3,1±0,6 |
—— |
—— |
3,4±0,8 |

Figure 1. Exspression of biomarkers
of salivary fluid.